ストックスクリーナーアプリを入手
8.98
0.99%
-0.09
アフターアワーズ：
9.15
0.17
+1.89%
前日終値:
$9.07
開ける：
$9.02
24時間の取引高:
374.25K
Relative Volume:
1.09
時価総額：
$294.53M
収益：
$65.42M
当期純損益:
$-32.96M
株価収益率:
-7.0709
EPS:
-1.27
ネットキャッシュフロー:
$-19.87M
1週間 パフォーマンス:
-0.88%
1か月 パフォーマンス:
-15.04%
6か月 パフォーマンス:
-38.85%
1年 パフォーマンス:
+10.59%
1日の値動き範囲:
$8.79
$9.125
1週間の範囲:
$8.79
$9.61
52週間の値動き範囲:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
NPCE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.98 | 297.48M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-21 | 開始されました | UBS | Buy |
| 2024-03-14 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | 開始されました | Leerink Partners | Outperform |
| 2023-11-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-08-24 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 開始されました | Lake Street | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 開始されました | Robert W. Baird | Outperform |
| 2021-05-17 | 開始されました | JP Morgan | Overweight |
| 2021-05-17 | 開始されました | Morgan Stanley | Overweight |
| 2021-05-17 | 開始されました | SVB Leerink | Outperform |
| 2021-05-17 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Neuropace Inc (NPCE) 最新ニュース
NeuroPace Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia
Is NeuroPace Inc. a good long term investmentTremendous growth opportunities - Autocar Professional
What analysts say about NeuroPace Inc. stockExceptional financial outcomes - PrintWeekIndia
What drives NeuroPace Inc. stock priceFree Trading Strategy Suggestions - PrintWeekIndia
NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey - MSN
NeuroPace secures $75M credit facility with MidCap Financial - MSN
(NPCE) Proactive Strategies - news.stocktradersdaily.com
What makes NeuroPace Inc. stock price move sharplyFree Investing Community - Newser
How NeuroPace Inc. stock performs during market volatilityFree Stock Selection - Newser
Why NeuroPace Inc. stock attracts strong analyst attentionFree Stock Market Query - Newser
NeuroPace appoints Patrick Williams as CFO - MSN
NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles By Investing.com - Investing.com South Africa
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, ... - Bluefield Daily Telegraph
NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles - Investing.com
NeuroPaceVolatile, Uncertain, But Promising (NASDAQ:NPCE) - Seeking Alpha
NeuroPace Inc (NPCE) Trading Down 3.93% on Jun 27 - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc.NPCE - WV News
NeuroPace stock maintains outperform rating at Leerink on expansion outlook - Investing.com
NeuroPace stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com UK
NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm - WV News
NeuroPace's NAUTILUS Fallout: A Shareholder's Guide to Fraud Claims and Recovery - AInvest
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load? - simplywall.st
Metric Analysis: NeuroPace Inc (NPCE)’s Key Ratios in the Limelight - DWinneX
10 Best NASDAQ Stocks Under $50 to Buy - Insider Monkey
Two Sigma Investments LP Invests $293,000 in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Neuropace Inc (NPCE) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
大文字化:
|
ボリューム (24 時間):